R&D Systems ProDots Human LIF Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems PRD773450
DescriptionThe ProDots Recombinant Human LIF Protein is derived from E. coli. The ProDots Recombinant Human LIF Protein has been validated for the following applications: Bioactivity.
|Observed M.W.: 19 kDa, reducing conditions.; Theoretical M.W.: 19.6 kDa|
|E. coli-derived human LIF protein Pro24-Phe202|
|<0.01 EU per 1μg of the protein by the LAL method.|
|Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323.|
|For a stock solution, reconstitute at 100 μg/mL in sterile PBS, or simply roll ProDot™ directly into cell culture medium for immediate use.|
|E. coli-derived Pro24 - Phe202|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt at room temperature as supplied. 12 months from date of receipt at 2-8° C as supplied. 1 month at 2-8° C under sterile conditions after reconstitution. 3 months at -20 to -80° C under sterile conditions after reconstitution.|
|CDF, D factor, DIA, differentiation inhibitory activity, differentiation stimulating factor, Differentiation-stimulating factor, Emfilermin, HILDA, HILDAcholinergic differentiation factor, leukemia inhibitory factor, leukemia inhibitory factor (cholinergic differentiation factor), Melanoma-derived LPL inhibitor, MLPLI|